About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
A Therapeutic Approach for Two Patients with Multiple Supernumerary and Impacted Teeth
Brigitte  Wendl1, Alfred Peter Muchitsch1, Helmut  Droschl1, Gert Santler2, Astrid Truschnegg3, Norbert Jakse3
1Department of Orthodontics and Dentofacial Orthopedics, 3Department of Oral Surgery and Radiology, Medical University of Graz, Austria, Auenbruggerplatz 12, A-8036  Graz, Austria; 2Department of Oral Surgery and Radiology - Medical University of Wels-Grieskirchen, 4710 Grieskirchen, Austria. 
Corresponding Author:
Priv. Doz. Dr. Brigitte Wendl
Email: brigitte.wendl@medunigraz.at
Received: 24-OCT-2015 Accepted: 31-DEC-2015 Published Online: 05-FEB-2016
DOI: http://dx.doi.org/10.17659/01.2016.0014
Abstract
The occurrence of multiple supernumerary teeth in the absence of systemic disease is uncommon and therapy requires interdisciplinary collaboration.  We hereby report cases and treatment process of two brothers having 10 and 7 supernumerary and impacted teeth with class III symptoms.
Keywords : Cysts, Dentition, Impacted Tooth, Supernumerary Tooth, Tooth Eruption.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025